TY - JOUR
T1 - Transvenous stimulation of the renal sympathetic nerves increases systemic blood pressure
T2 - A potential new treatment option for neurocardiogenic syncope
AU - Madhavan, Malini
AU - Desimone, Christopher V.
AU - Ebrille, Elisa
AU - Mulpuru, Siva K.
AU - Mikell, Susan B.
AU - Johnson, Susan B.
AU - Suddendorf, Scott H.
AU - Ladewig, Dorothy J.
AU - Gilles, Emily J.
AU - Danielsen, Andrew J.
AU - Asirvatham, Samuel J.
N1 - Publisher Copyright:
© 2014 Wiley Periodicals, Inc.
PY - 2014/10/1
Y1 - 2014/10/1
N2 - Renal Vein Stimulation Increases Blood Pressure Background Neurocardiogenic syncope (NCS) is a common and sometimes debilitating disorder, with no consistently effective treatment. NCS is due to a combination of bradycardia and vasodilation leading to syncope. Although pacemaker devices have been tried in treating the bradycardic aspect of NCS, no device-based therapy exists to treat the coexistent vasodilation that occurs. The renal sympathetic innervation has been the target of denervation to treat hypertension. We hypothesized that stimulation of the renal sympathetic nerves can increase blood pressure and counteract vasodilation in NCS. Methods and Results High-frequency stimulation (800-900 pps, 10 V, 30-200 seconds) was performed using a quadripolar catheter in the renal vein of 7 dogs and 1 baboon. A significant increase in blood pressure (BP; mean [SD] systolic BP 117 [±28] vs. 128 [±33], diastolic BP 75 [±19] vs. 87 [±29] mmHg) was noted during the stimulation, which returned to baseline after cessation of stimulation. The mean increase in systolic and diastolic BP was 13.0 (±3.3) (P = 0.006) and 10.2 (±4.6) (P = 0.08), respectively. Conclusion We report the first ever study of feasibility and safety of high-frequency electrical stimulation of the renal sympathetic innervation to increase BP in animal models. This has potential applications in the treatment of hypotensive states such as NCS.
AB - Renal Vein Stimulation Increases Blood Pressure Background Neurocardiogenic syncope (NCS) is a common and sometimes debilitating disorder, with no consistently effective treatment. NCS is due to a combination of bradycardia and vasodilation leading to syncope. Although pacemaker devices have been tried in treating the bradycardic aspect of NCS, no device-based therapy exists to treat the coexistent vasodilation that occurs. The renal sympathetic innervation has been the target of denervation to treat hypertension. We hypothesized that stimulation of the renal sympathetic nerves can increase blood pressure and counteract vasodilation in NCS. Methods and Results High-frequency stimulation (800-900 pps, 10 V, 30-200 seconds) was performed using a quadripolar catheter in the renal vein of 7 dogs and 1 baboon. A significant increase in blood pressure (BP; mean [SD] systolic BP 117 [±28] vs. 128 [±33], diastolic BP 75 [±19] vs. 87 [±29] mmHg) was noted during the stimulation, which returned to baseline after cessation of stimulation. The mean increase in systolic and diastolic BP was 13.0 (±3.3) (P = 0.006) and 10.2 (±4.6) (P = 0.08), respectively. Conclusion We report the first ever study of feasibility and safety of high-frequency electrical stimulation of the renal sympathetic innervation to increase BP in animal models. This has potential applications in the treatment of hypotensive states such as NCS.
KW - blood pressure
KW - neurocardiogenic syncope
KW - renal nerve stimulation
KW - sympathetic nervous system
KW - syncope
UR - http://www.scopus.com/inward/record.url?scp=84908483038&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908483038&partnerID=8YFLogxK
U2 - 10.1111/jce.12466
DO - 10.1111/jce.12466
M3 - Article
C2 - 24902981
AN - SCOPUS:84908483038
SN - 1045-3873
VL - 25
SP - 1115
EP - 1118
JO - Journal of Cardiovascular Electrophysiology
JF - Journal of Cardiovascular Electrophysiology
IS - 10
ER -